Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin monitoring during arterial vascular surgery
NL-OMON38796Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of heparin in Vasculopathy, sponsored by Vrije University Medical Center. Primary endpoint: Individual target heparin concentration. Started Jan 2014; status: active, not recruiting.
02
Drugs
heparin
03
Conditions
Vasculopathy
Beyond the preview
Go deeper on NL-OMON38796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38796.